In many instances , no or minimal attempts to screen were undertaken or reported .
Background Subacromial shoulder pain is a common clinical presentation with much diagnostic uncertainty .
Some of this uncertainty relates to the involvement of the cervical spine as a source or contribution to subacromial shoulder pain .
Currently , there is no accepted method of screening of the cervical spine in the presence of subacromial shoulder pain , which risks patients receiving misguided and /or ineffective interventions .
Objective To evaluate approaches used to screen the cervical spine in patients with subacromial shoulder pain .
A double-blind randomised controlled study comparing subacromial injection of tenoxicam or methylprednisolone in patients with subacromial impingement.
We have carried out a prospect i ve double-blind r and omised controlled trial to compare the efficacy of a single subacromial injection of the non-steroidal anti-inflammatory drug , tenoxicam , with a single injection of methylprednisolone in patients with subacromial impingement . A total of 58 patients were r and omly allocated into two groups . Group A received 40 mg of methylprednisolone and group B 20 mg of tenoxicam as a subacromial injection along with lignocaine . The Constant-Murley shoulder score was used as the primary outcome measure and the Disability of Arm , Shoulder and H and ( DASH ) and the Oxford Shoulder Score ( OSS ) as secondary measures . Six weeks after injection the improvement in the Constant-Murley score was significantly greater in the methylprednisolone group ( p = 0.003 ) than in the tenoxicam group . The improvement in the DASH score was greater in the steroid group and the difference was statistically significant and consistent two ( p < 0.01 ) , four ( p < 0.01 ) and six weeks ( p < 0.020 ) after the injection . The improvement in the OSS was consistently greater in the steroid group than in the tenoxicam group . Although the difference was statistically significant at two ( p < 0.001 ) and four ( p = 0.003 ) weeks after the injection , it was not at six weeks ( p = 0.055 ) . Subacromial injection of tenoxicam does not offer an equivalent outcome to subacromial injection of corticosteroid at six weeks . Corticosteroid is significantly better than tenoxicam for improving shoulder function in tendonitis of the rotator cuff after six weeks
In many instances , no or minimal attempts to screen were undertaken or reported .
Background Subacromial shoulder pain is a common clinical presentation with much diagnostic uncertainty .
Some of this uncertainty relates to the involvement of the cervical spine as a source or contribution to subacromial shoulder pain .
Currently , there is no accepted method of screening of the cervical spine in the presence of subacromial shoulder pain , which risks patients receiving misguided and /or ineffective interventions .
Objective To evaluate approaches used to screen the cervical spine in patients with subacromial shoulder pain .